Preferred Label : insulin, regular, human;
MeSH definition : Regular insulin preparations that contain the HUMAN insulin peptide sequence.;
CISMeF synonym : lilly brand of recombinant human insulin;
MeSH hyponym : humulin S; Humulin;
Is substance : O;
Origin ID : D061386;
UMLS CUI : C0795635;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Record concept(s)
Related MeSH Supplementary Concept(s)
- albulin [MeSH Supplementary Concept]
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT
Regular insulin preparations that contain the HUMAN insulin peptide sequence.
https://www.has-sante.fr/portail/jcms/c_2770190/fr/umuline
https://www.has-sante.fr/portail/jcms/c_1363131/umuline
https://www.has-sante.fr/portail/jcms/c_560696/fr/umuline-nph-pen
2017
false
France
French
Isophane Insulin, Human
insulin, isophane
diabetes mellitus
hypoglycemic agents
pregnancy
insulin (human)
insulin, regular, human
recombinant proteins
biphasic insulins
insulin, Short-Acting
insulin (human)
insulin (human)
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_2608676/fr/actrapid-insulatard-mixtard
http://www.has-sante.fr/portail/jcms/c_1278879/actrapid-mixtard-insulatard
2016
false
France
French
Isophane Insulin, Human
evaluation of the transparency committee
biphasic insulins
insulin, isophane
insulin (human)
insulin (human)
treatment outcome
hypoglycemic agents
insurance, health, reimbursement
injections, subcutaneous
diabetes mellitus
insulin, Short-Acting
recombinant proteins
insulin, regular, human
insulin (human)
---
http://www.has-sante.fr/portail/jcms/c_1774160/fr/insuman-implantable
http://www.has-sante.fr/portail/jcms/c_1774160/fr/insuman-implantable-insuline-humaine-antidiabetique
2014
false
false
false
France
French
evaluation of the transparency committee
insulin, regular, human
diabetes mellitus, type 1
treatment outcome
adult
insulin (human)
hypoglycemic agents
insulin infusion systems
implantable programmable insulin pump
recombinant proteins
guidelines for drug use
---
https://www.ema.europa.eu/medicines/human/EPAR/Actraphane
2012
Non renseigné
French
English
syndication feed
diabetes mellitus
hypoglycemic agents
insulin, isophane
insulin (human)
biphasic insulins
hypoglycemic agents
insulin, isophane
biphasic insulins
recombinant proteins
insulin, Short-Acting
insulin, Short-Acting
insulin, regular, human
insulin, regular, human
drug evaluation
summary of product characteristics
package leaflet
---
https://www.ema.europa.eu/medicines/human/EPAR/Protaphane
2012
United Kingdom
French
English
syndication feed
hypoglycemic agents
insulin, isophane
diabetes mellitus
hypoglycemic agents
insulin, long-acting
treatment outcome
drug evaluation
hypoglycemic agents
insulin, isophane
insulin, isophane
insulin (human)
insulin, regular, human
insulin, regular, human
recombinant proteins
drug evaluation
summary of product characteristics
package leaflet
---
https://www.ema.europa.eu/medicines/human/EPAR/insulin-human-winthrop
2012
false
United Kingdom
English
French
syndication feed
hypoglycemic agents
diabetes mellitus
hyperglycemic hyperosmolar nonketotic coma
diabetic ketoacidosis
insulin
insulin, long-acting
hypoglycemic agents
insulin, long-acting
drug interactions
pregnancy
breast feeding
insulin, isophane
insulin, isophane
treatment outcome
drug evaluation
drug approval
drug labeling
insulin (human)
insulin, regular, human
insulin (human)
insulin (human)
insulin, Short-Acting
insulin, Short-Acting
biphasic insulins
biphasic insulins
insulin, regular, human
package leaflet
drug evaluation
summary of product characteristics
---
https://www.ema.europa.eu/medicines/human/EPAR/velosulin
2008
false
United Kingdom
English
French
syndication feed
insulin, Short-Acting
drug evaluation
hypoglycemic agents
diabetes mellitus
treatment outcome
insulin (human)
recombinant proteins
insulin, regular, human
infusions, subcutaneous
injections, subcutaneous
injections, intravenous
drug evaluation
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62619550
2008
France
French
insulin, Short-Acting
insulin, Short-Acting
injections, intramuscular
pharmaceutical solutions
injections, subcutaneous
hypoglycemic agents
hypoglycemic agents
recombinant proteins
drug interactions
pregnancy
drug compounding
drug storage
insulin (human)
insulin, regular, human
insulin, regular, human
package leaflet
summary of product characteristics
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68705554
2008
France
French
insulin, Short-Acting
insulin, Short-Acting
injections, subcutaneous
injections, intramuscular
pharmaceutical solutions
recombinant proteins
drug approval
drug interactions
pregnancy
drug compounding
drug storage
hypoglycemic agents
hypoglycemic agents
insulin (human)
insulin, regular, human
insulin, regular, human
package leaflet
summary of product characteristics
---
https://minerva-ebp.be/fr/article/659
2007
false
false
minerva-ebm.be
Belgium
French
comparative study
diabetes mellitus
drug evaluation
insulin, Short-Acting
hypoglycemic agents
insulin
treatment outcome
Glycated Hemoglobin
hypoglycemia
quality of life
insulin, regular, human
meta-analysis as topic
insulin (human)
insulin aspart
insulin lispro
insulin glulisine
insulin lispro
insulin aspart
insulin glulisine
critical appraisal or critical reading
---
https://www.ema.europa.eu/medicines/human/EPAR/Monotard
2006
United Kingdom
English
French
syndication feed
diabetes mellitus, type 1
diabetes mellitus, type 2
hypoglycemic agents
insulin, long-acting
treatment outcome
drug evaluation
injections, subcutaneous
insulin (human)
hypoglycemic agents
insulin, long-acting
insulin, regular, human
insulin, regular, human
recombinant proteins
package leaflet
drug evaluation
summary of product characteristics
---